CRP and rectal cancer: Multivariate analysis using a Cox proportional hazards model showed that CRP was an independent predictor of DFS (Hazard Ratio (HR) = 5.481; 95% CI 1.542–19.485) and OS (HR = 6.096; 95% CI 1.267–29.323) in patients with rectal cancer treated with nCRT.